Targeting hypoxia at the forefront of anticancer immune responses

OncoImmunology

Volumn 3, Issue 12, 2014, Pages 1-3

  Noman, Muhammad Zaeem ^a   Chouaib, Salem ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

HIF 1 ; hypoxia; IL 10; immune suppression; MDSC; PD L1

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 10; INTERLEUKIN 6; PROGRAMMED DEATH 1 LIGAND 1; TRANSFORMING GROWTH FACTOR BETA1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; DNA DAMAGE CHECKPOINT; HYPOXIA; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR REGRESSION;

EID: 84938803844     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/21624011.2014.954463     Document Type: Article

References (10)

1. D.M.Pardoll. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; http://dx.doi.org/10.1038/nrc3239
2. M.Z.Noman, H.Benlalam, M.Hasmim, S.Chouaib. Cytotoxic T cells—stroma interactions. Bull Cancer 2011; 98:E19-24; PMID:21339092; http://dx.doi.org/10.1684/bdc.2010.1295
3. M.Z.Noman, S.Buart, J.Van Pelt, C.Richon, M.Hasmim, N.Leleu, W.M.Suchorska, A.Jalil, Y.Lecluse, F.El Hage, The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J Immunol 2009; 182:3510-21; PMID:19265129; http://dx.doi.org/10.4049/jimmunol.0800854
4. M.Z.Noman, B.Janji, G.Berchem, F.Mami-Chouaib, S.Chouaib. Hypoxia-induced autophagy: a new player in cancer immunotherapy? Autophagy 2012; 8:704-6; PMID:22441015; http://dx.doi.org/10.4161/auto.19572
5. M.Hasmim, M.Z.Noman, Y.Messai, D.Bordereaux, G.Gros, V.Baud, S.Chouaib. Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-beta1. J Immunol 2013; 191:5802-6; PMID:24227785; http://dx.doi.org/10.4049/jimmunol.1302140
6. D.I.Gabrilovich, S.Ostrand-Rosenberg, V.Bronte. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; http://dx.doi.org/10.1038/nri3175
7. M.Z.Noman, G.Desantis, B.Janji, M.Hasmim, S.Karray, P.Dessen, V.Bronte, S.Chouaib. PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 2014; 211:781-90; PMID:24778419; http://dx.doi.org/10.1084/jem.20131916
8. T.J.Curiel, S.Wei, H.Dong, X.Alvarez, P.Cheng, P.Mottram, R.Krzysiek, K.L.Knutson, B.Daniel, M.C.Zimmermann, Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9:562-7; PMID:12704383; http://dx.doi.org/10.1038/nm863
9. I.B.Barsoum, C.A.Smallwood, D.R.Siemens, C.H.Graham. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 2014; 74:665-74; PMID:24336068; http://dx.doi.org/10.1158/0008-5472.CAN-13-0992
10. A.L.Doedens, A.T.Phan, M.H.Stradner, J.K.Fujimoto, J.V.Nguyen, E.Yang, R.S.Johnson, A.W.Goldrath. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol 2013; 14:1173-82; PMID:24076634; http://dx.doi.org/10.1038/ni.2714